Cleared Special

K253518 - FX CorAL 40 (FDA 510(k) Clearance)

Also includes:
FX CorAL 50
Dec 2025
Decision
36d
Days
Class 2
Risk

K253518 is an FDA 510(k) clearance for the FX CorAL 40. This device is classified as a Dialyzer, High Permeability With Or Without Sealed Dialysate System (Class II - Special Controls, product code KDI).

Submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on December 18, 2025, 36 days after receiving the submission on November 12, 2025.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5860.

Submission Details

510(k) Number K253518 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 2025
Decision Date December 18, 2025
Days to Decision 36 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code KDI — Dialyzer, High Permeability With Or Without Sealed Dialysate System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5860

Similar Devices — KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System

All 17
ELISIO™-H
K260533 · Nipro Medical Corporation · Mar 2026
multiFlux 130 (F00013123)
K252459 · Fresenius Medical Care Renal Therapies Group, LLC · Feb 2026
2008T HD SYS. CDX BLUESTAR (191124)
K243237 · Fresenius Medical Care Renal Therapies Group, LLC · Jun 2025
5008X Hemodialysis System
K243505 · Fresenius Medical Care Renal Therapies Group, LLC · May 2025
DHF 0.2 Hemoconcentrator (DHF 02)
K243264 · Sorin Group Italia S.R.L. · Apr 2025
FX CorAL 40 (F00009214)
K242053 · Fresenius Medical Care Renal Therapies Group, LLC · Mar 2025